Nevro Corp (NYSE:NVRO)
$ 4.58 0.26 (6.02%) Market Cap: 171.62 Mil Enterprise Value: 141.17 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 43/100

Nevro Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 09:30PM GMT
Release Date Price: $85.73 (+8.49%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Robbie Marcus, the Med Tech analyst at JPMorgan. I'm very happy to have our next session with Nevro. Going to introduce CEO, Keith Grossman. Joining us later for Q&A will also be Rod MacLeod, the CFO; and Julie Tracy -- or sorry, Julie Dewey in Investor Relations, as you all know. So Keith, I'm going to turn it over to you for the presentation. I'll join you in a little bit for some Q&A.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Okay. Sounds good. Thank you, Robbie, and thanks, everyone, for joining us in this time slot and Happy New Year. For those of you who are dialed-in through the JPMorgan portal, we'll go ahead and control the movement of the slides. For those of you who might be following the deck off of our website, I'll try, if I can, to remember to give you slide numbers so you can follow along as well.

All right. Here we go. So I'd refer you to our safe harbor language in our public filings for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot